PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 1, 2022Annals of Internal Medicine84 citationsOpen Access

First-Line Therapy for Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists

JCJin ChoiCalifornia Pacific Medical CenterAWAaron N. WinnUniversity of Illinois ChicagoMSM. Reza SkandariNIHR Imperial Biomedical Research Centre

Key Points

Key points are not available for this paper at this time.

Abstract

American Diabetes Association.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Choi et al. (2022) studied this question.

synapsesocial.com/papers/69d9845bc7f0c3ae80a3dcbahttps://doi.org/10.7326/m21-2941
Ask AI
Helpful
Bookmark
Share
View Full Paper